Editorial Board

• Jeffrey K. Actor, Texas Medical Center, USA
• Alexander S. Apt, Central Institute for Tuberculosis, Russia
• Mark S. Baird, Bangor University, United Kingdom
• Michael R. Barer, University of Leicester, United Kingdom
• Christos Chouaid, Assistance Publique - Hôpitaux de Paris, France
• Luis E Cuevas, Liverpool University, United Kingdom
• Karl Drlica, University of Medicine and Dentistry, New Jersey, USA
• Brian Eley, University of Cape Town, South Africa
• Carlo Garzelli, Università di Pisa, Italy
• Edward A. Graviss, Methodist Hospital System, USA
• Jacques Grosset, Johns Hopkins University, USA
• Abdulrahman S. Hammond, University of Bamako, Mali
• S. E. Hasnain, University of Hyderabad, India
• R. L. Hunter, University of Texas Health Sciences Center (UTHSC), USA
• Juraj Ivanyi, King's College London, United Kingdom
• Vincent Jarlier, Université Pierre et Marie Curie, France
• Paul R. Klatser, Royal Tropical Institute, The Netherlands
• José R. Lapa e Silva, Rio de Janeiro Federal University, Brazil
• Roy Mugerwa, Makerere University, Uganda
• T. Ottenhoff, Leiden University, The Netherlands
• David C. Perlman, Beth Israel Medical Center, USA
• Nalin Rastogi, Institut Pasteur, France
• Giovanna Riccardi, Università degli studi di Pavia, Italy
• Menico Rizzi, Università del Piemonte Orientale, Italy
• W. N. Rom, New York University, USA
• Euzenir N. Sarno, Oswaldo Cruz Institute, Brazil
• Sarman Singh, All India Institute of Medical Sciences, India
• Jeffrey R. Starke, Baylor College of Medicine, USA
• Isamu Sugawara, Research Institute of Tuberculosis, Japan
• Thelma E. Tupasi, Tropical Disease Foundation, Philippines
• Robert S. Wallis, Pfizer, USA
• Robert J. Wilkinson, Imperial College London, United Kingdom